Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Lupus Nephritis”

74 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 74 results

Early research (Phase 1)Study completedNCT04128579
What this trial is testing

Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis

Who this might be right for
Lupus ErythematosusLupus Nephritis
Biocon Limited 52
Testing effectiveness (Phase 2)Looking for participantsNCT07229742
What this trial is testing

A Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the Treatment of Patients With Active Lupus Nephritis

Who this might be right for
Active Lupus Nephritis
Guangdong Hengrui Pharmaceutical Co., Ltd 51
Testing effectiveness (Phase 2)Looking for participantsNCT07053800
What this trial is testing

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Autolus Limited 35
Testing effectiveness (Phase 2)WithdrawnNCT06153095
What this trial is testing

IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Lyell Immunopharma, Inc.
Testing effectiveness (Phase 2)Study completedNCT01085097
What this trial is testing

Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Teva Branded Pharmaceutical Products R&D, Inc. 46
Testing effectiveness (Phase 2)UnknownNCT01863641
What this trial is testing

The Effect of Calcitriol on Progress and Activity of Lupus Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Guilan University of Medical Sciences 50
Large-scale testing (Phase 3)Ended earlyNCT00430677
What this trial is testing

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Bristol-Myers Squibb 423
Post-approval studies (Phase 4)Study completedNCT00371319
What this trial is testing

Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Tuen Mun Hospital 150
Large-scale testing (Phase 3)Active Not RecruitingNCT05126277
What this trial is testing

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 452
Testing effectiveness (Phase 2)Study completedNCT02949973
What this trial is testing

Aurinia Early Urinary Protein Reduction Predicts Response

Who this might be right for
Lupus Nephritis
Aurinia Pharmaceuticals Inc. 10
Testing effectiveness (Phase 2)Study completedNCT05714670
What this trial is testing

The Effect of Curcumin on the Clinical Outcome of Pediatric Patients with Active Lupus Nephritis

Who this might be right for
Lupus NephritisSLE Nephritis
Ain Shams University 72
Post-approval studies (Phase 4)UnknownNCT05495893
What this trial is testing

MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN

Who this might be right for
Mycophenolate MofetilCyclophosphamideLupus Nephritis
Second Xiangya Hospital of Central South University 224
Not applicableNot Yet RecruitingNCT06520670
What this trial is testing

Urinary G3BP as a Novel Biomarker in Lupus Nephritis

Who this might be right for
Lupus Nephritis
Assiut University 70
Early research (Phase 1)Looking for participantsNCT07491900
What this trial is testing

HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erthematosus (SLE)Lupus Nephritis (LN)Extra-renal Lupus (ERL)
Hinge Bio 30
Not applicableStudy completedNCT01731054
What this trial is testing

Functional MRI in Lupus Nephritis

Who this might be right for
HealthyLupus Nephritis
Biogen 50
Testing effectiveness (Phase 2)WithdrawnNCT06419205
What this trial is testing

Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

Who this might be right for
IgA NephropathyLupus Nephritis (LN)C3 (Complement Component 3) Glomerulopathy
Q32 Bio Inc.
Testing effectiveness (Phase 2)Study completedNCT04643470
What this trial is testing

Zanubrutinib in Participants With Active Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
BeiGene 177
Large-scale testing (Phase 3)Study completedNCT01639339
What this trial is testing

Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Human Genome Sciences Inc., a GSK Company 448
Testing effectiveness (Phase 2)Looking for participantsNCT05039619
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

Who this might be right for
Lupus Nephritis
Hoffmann-La Roche 40
Testing effectiveness (Phase 2)Ended earlyNCT04376827
What this trial is testing

Guselkumab in Participants With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Janssen Research & Development, LLC 33
Load More Results